Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:51 PM
Ignite Modification Date:
2025-12-24 @ 11:51 PM
NCT ID:
NCT02982551
Eligibility Criteria:
Inclusion Criteria:
* Body mass index between 18 and 24
* HOMA-IR \< 1.55 (homeostatic model assessment of insulin resistance - ((glucose x insulin) / 405)).
Exclusion Criteria:
* Current or lifetime history of any cardiovascular disease or surgery (including hypertension, stroke, myocardial infarction, congestive heart failure, atrial or ventricular arrhythmias, coronary bypass, carotid artery, or peripheral vascular surgery)
* Current or lifetime history of cancer, a chronic kidney or liver condition, type I or II diabetes, or any pulmonary or respiratory disease
* Current or lifetime diagnoses of any substance abuse
* Positive urine drug screen
* Current or lifetime use of glucocorticoid medications for \>1 month
* A previous cerebrovascular accident or trauma involving loss of consciousness
* Previous neurosurgery or history of a neurological condition
* Pregnancy (females)
* Claustrophobia
* Ferrous metallic implants or any surgically placed medical device not cleared for safety at 3Tesla MRI strength
* Peripheral vascular disease
* Liver, kidney, or active blood disease
* Peripheral neuropathy
* Anemia (hematocrit \<34%)
* Inability and/or willingness to comply with the protocol as written
* Fasting glucose \> 126 mg/dL
* Currently taking blood thinners such as coumadin, Lovenox, etc.
* Currently taking any medications that can alter glucose homeostasis (steroids, glucocorticoids, nicotinic acid)
* Current use of any psychotropic medications (SSRI, SNRI, etc.)
* Currently taking thiazolidinediones or insulin
* Currently use of statins or anti-hypertensive medications
* Use of medications related to HIV that can affect insulin sensitivity. We will NOT specifically test for HIV serostatus.
* Females currently on hormone replacement therapy (HRT) less than 6 months
* Participants will be instructed to abstain from eating, drinking (other than water), smoking and exercise for the 12 hours prior to each study visit.
* Being left handed
* Body mass index above 24 or below 18
* Milk allergy / lactose intolerance
* Polycystic ovary syndrome
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
21 Years
Maximum Age:
30 Years
Study:
NCT02982551
Study Brief:
Protocol Section:
NCT02982551